Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kapil Moza

Neurological Surgery Thousand Oaks, CA Medical Doctor

NPI 1841231248 CMS profile 356629

313 S Moorpark Rd, Thousand Oaks, CA 91361

Open in the dashboard

General payments

$11,394

350 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kapil Moza of Thousand Oaks, CA is reported in the CMS Open Payments database as having received $11,394 across 350 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 71st percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,795 97
2024 General $1,422 47
2023 General $1,002 33
2022 General $1,803 48
2021 General $1,976 46
2020 General $617 21
2019 General $1,779 58

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kapil Moza
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Kapil Moza were reported at $2,795. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Kapil Moza Neurological Surgery median Middle half National median
2019 $1,779 $582 $138–$3,006 $163
2020 $617 $294 $76–$2,174 $114
2021 $1,976 $387 $105–$2,432 $132
2022 $1,803 $542 $139–$2,989 $149
2023 $1,002 $534 $145–$2,697 $160
2024 $1,422 $574 $155–$3,046 $164
2025 $2,795 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $2,921 112 payments
  2. Abbott Laboratories $2,548 89 payments
  3. NuVasive, Inc. $1,208 32 payments
  4. DePuy Synthes Sales Inc. $1,021 50 payments
  5. Alphatec Spine, Inc $853 6 payments
  6. Stimwave Technologies Incorporated $282 10 payments
  7. Zimmer Biomet Holdings, Inc. $279 7 payments
  8. Lilly USA, LLC $214 6 payments
  9. Centinel Spine, LLC $201 3 payments
  10. Boston Scientific Corporation $173 7 payments
  11. Other $1,694 28 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,675 347 payments
  2. Travel and Lodging $718 3 payments
Products named General payments · program years 2019–2025
  1. CORRIDOR $972 35 payments
  2. PROCLAIM $877 20 payments
  3. ACP $812 31 payments
  4. Pulse $652 15 payments
  5. Simplify Cervical Artificial Disc $590 20 payments
  6. AttraX $561 12 payments
  7. ETERNA $497 8 payments
  8. LAMITRODE TRIPOLE $312 9 payments
  9. SYMPHONY $292 12 payments
  10. Excelsius - GPS $273 6 payments
  11. Other $6,271 218 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

350 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record